MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Beta thalassemia (D56.1)

Evalytics 22 January at 02.18 PM

FDA clears first CRISPR treatment for a second disease, beta thalassemia

The FDA has approved Casgevy, a CRISPR-based medicine, for treating beta thalassemia, a serious blood disorder. This innovative treatment, also used for sickle cell disease, modifies stem cells to boost hemoglobin production, offering a new option for patients.